Detalhe da pesquisa
1.
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study.
Gynecol Oncol
; 175: 182-189, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37355448
2.
Targeting cervical cancer: Is there a role for poly (ADP-ribose) polymerase inhibition?
J Cell Physiol
; 235(6): 5050-5058, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31912897
3.
Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial).
BMC Cancer
; 15: 359, 2015 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25943747
4.
Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.
Eur J Cancer
; 203: 114039, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598922
5.
The Revolution of Immunotherapy in Gynecological Cancers: The Lazarus Effect in Endometrial Cancer.
J Clin Med
; 12(17)2023 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37685607
6.
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35101944
7.
Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer.
Curr Cancer Drug Targets
; 2022 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045535
8.
Early-onset malignant phyllodes breast tumor in a patient with germline pathogenic variants in NF1 and BRCA1 genes.
Fam Cancer
; 20(3): 195-199, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33210232
9.
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer.
Gynecol Oncol Rep
; 38: 100880, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34926761
10.
Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option?
Expert Opin Drug Saf
; 20(6): 641-650, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33555963
11.
First-Line Treatment with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research.
Cancer Manag Res
; 12: 5479-5489, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32765062
12.
Parp inhibitors as maintenance treatment in platinum sensitive recurrent ovarian cancer: An updated meta-analysis of randomized clinical trials according to BRCA mutational status.
Cancer Treat Rev
; 80: 101909, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31629204
13.
Fertility preservation in ovarian tumours.
Ecancermedicalscience
; 12: 885, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30679952
14.
Risk-reducing Salpingo-Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Series.
Anticancer Res
; 37(9): 5241-5248, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28870960
15.
Fertility preservation in women with borderline ovarian tumours.
Cancer Treat Rev
; 49: 13-24, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27428850
16.
Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysis.
Tumori
; 100(4): 426-31, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25296592